APA (7th ed.) Citation

T, S., Y, I., M, S., O, Y., Y, T., F, K., . . . N, K. (2025). One Year Outcomes of Zilver PTX Versus Eluvia for Femoropopliteal Disease in Real-World Practice: REALDES Study. Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists, 32(2), 490. https://doi.org/10.1177/15266028231179861

Chicago Style (17th ed.) Citation

T, Shibata, et al. "One Year Outcomes of Zilver PTX Versus Eluvia for Femoropopliteal Disease in Real-World Practice: REALDES Study." Journal of Endovascular Therapy : An Official Journal of the International Society of Endovascular Specialists 32, no. 2 (2025): 490. https://doi.org/10.1177/15266028231179861.

MLA (9th ed.) Citation

T, Shibata, et al. "One Year Outcomes of Zilver PTX Versus Eluvia for Femoropopliteal Disease in Real-World Practice: REALDES Study." Journal of Endovascular Therapy : An Official Journal of the International Society of Endovascular Specialists, vol. 32, no. 2, 2025, p. 490, https://doi.org/10.1177/15266028231179861.